New Zealand Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:New Zealand Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3302
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ニュージーランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
New Zealand Pharmaceuticals Ltd (NZP) a subsidiary of Archer Capital, manufactures and supplies pharmaceutical intermediates and diagnostic products for pharmaceutical and microbiological media companies. It also offers biochemicals and natural extracts for health, cosmetic, biotechnology, food, and aquaculture industries. It extracts and purifies biochemicals from by-products of the New Zealand meat processing industry. The company’s products include dietary supplements, carbohydrates, microbiological and cell culture media, pharmaceutical intermediates and ingredients, feed ingredients, excipients and blackcurrant extract. NZP uses various technologies such as enzyme and chemical hydrolyses; large scale aqueous and organic solvent extractions; ion-exchange purification, distillation, ultrafiltration, filtration and centrifugation; crystallisation, milling and chemical synthesis; and spray drying to manufacture its products. NZP is headquartered in Palmerston North, New Zealand.

New Zealand Pharmaceuticals Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Archer Capital Acquires 51% Stake in New Zealand Pharma from Direct Capital and Shareholders 10
Licensing Agreements 11
Altamira Signs License Agreement with New Zealand Pharma and The National Institutes of Health 11
Asset Transactions 12
Altamira Bio Acquires NIH License and CRADAs Relating to the Development of ManNAc from New Zealand Pharma 12
New Zealand Pharmaceuticals Ltd – Key Competitors 13
New Zealand Pharmaceuticals Ltd – Key Employees 14
New Zealand Pharmaceuticals Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts 2
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
New Zealand Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Archer Capital Acquires 51% Stake in New Zealand Pharma from Direct Capital and Shareholders 10
Altamira Signs License Agreement with New Zealand Pharma and The National Institutes of Health 11
Altamira Bio Acquires NIH License and CRADAs Relating to the Development of ManNAc from New Zealand Pharma 12
New Zealand Pharmaceuticals Ltd, Key Competitors 13
New Zealand Pharmaceuticals Ltd, Key Employees 14
New Zealand Pharmaceuticals Ltd, Subsidiaries 15
New Zealand Pharmaceuticals Ltd, Joint Venture 15

List of Figures
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[New Zealand Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AJ Lucas Group Ltd (AJL):企業の財務・戦略的SWOT分析
    AJ Lucas Group Ltd (AJL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mediclin AG (MED):企業の財務・戦略的SWOT分析
    Summary Mediclin AG (Mediclin) is a healthcare service provider that provides rehabilitation and medical care services. The center provides services in neuro-medicine with neurology, early neurological rehabilitation, neurosurgery and neuroradiology and psychological sciences, among others. It also …
  • UQM Technologies Inc (UQM):企業の財務・戦略的SWOT分析
    Summary UQM Technologies Inc (UQM) is a power system manufacturer that offers electric propulsion and generation solutions. The company’s products include fuel cell compression system, aircraft conditioning systems, full electric products, and hybrid components and generators. Its full electric prod …
  • Sarossa plc-製薬・医療分野:企業M&A・提携分析
    Summary Sarossa plc (Sarossa), formerly Sarossa Capital Limited, is an investment holding and management company. The company principally makes investment in and growth and development of businesses which present opportunities for value creation. It focuses on portfolio investment in major internati …
  • Banque Nationale Agricole SA:企業の戦略・SWOT・財務分析
    Banque Nationale Agricole SA - Strategy, SWOT and Corporate Finance Report Summary Banque Nationale Agricole SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Emisphere Technologies Inc (EMIS):企業の戦略的SWOT分析
    Emisphere Technologies Inc (EMIS) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Baosteel Group Corporation:企業のM&A・事業提携・投資動向
    Baosteel Group Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Baosteel Group Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • BioScrip Inc (BIOS):医療機器:M&Aディール及び事業提携情報
    Summary BioScrip Inc (BioScrip), formerly MIM Corp is a healthcare service provider that provides infusion care services. The hospital offers a range of infusion services, PBM services and respiratory services. It provides infusion therapy services such as antimicrobial drugs, factor replacement the …
  • Mereo Biopharma Group Plc (MPH):企業の財務・戦略的SWOT分析
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • AMEWAS, Inc.:企業の戦略・SWOT・財務分析
    AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMEWAS, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Precision System Science Co Ltd (7707):企業の財務・戦略的SWOT分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company provide products such as automated nucleic acid isolation system, large sample volume nucleic acid extract …
  • Corvidia Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Corvidia Therapeutics Inc (Corvidia Therapeutics) is a clinical stage biotechnology company that develops cardiovascular and cardio-renal therapies leveraging functional genomics. The company develops COR-001 for the treatment of chronic kidney disease on dialysis (under phase 2 stage), and …
  • Cargolux Airlines International S.A.:企業の戦略的SWOT分析
    Cargolux Airlines International S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Novozymes AS (NZYM B):製薬・医療:M&Aディール及び事業提携情報
    Summary Novozymes AS (Novozymes) is a biotech company that produces, markets and sells a range of industrial enzymes and microorganisms. The company provides enzymes for detergents, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning …
  • Voya Financial Inc:企業の戦略・SWOT・財務分析
    Voya Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Voya Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Presidio Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Presidio Pharmaceuticals Inc (Presidio) is a clinical-stage pharmaceutical company that discovers and develops small-molecule antiviral therapeutics. The company’s products include HCV NS5A, NS5B proteins, lead pan-genotypic HCV NS5A inhibitor, ravidasvir hydrochloride, protease inhibitor, f …
  • Spark New Zealand Ltd:企業の戦略・SWOT・財務分析
    Spark New Zealand Ltd - Strategy, SWOT and Corporate Finance Report Summary Spark New Zealand Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Walmart Chile S.A.:企業の戦略的SWOT分析
    Walmart Chile S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Kajima Corp (1812):企業の財務・戦略的SWOT分析
    Kajima Corp (1812) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Korres Natural Products SA:戦略・SWOT・企業財務分析
    Korres Natural Products SA - Strategy, SWOT and Corporate Finance Report Summary Korres Natural Products SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆